Increased Urinary Cystatin-C Levels Correlate with Reduced Renal Volumes in Neonates with Intrauterine Growth

Antonella Barbati1, Benito Cappuccini, Maria Cristina Aisa

  • 1Department of Surgical and Biomedical Sciences, Section of Obstetrics and Gynecology, University of Perugia, Perugia, Italy.

Neonatology
|January 13, 2016
PubMed

Insights

Intrauterine growth retardation (IUGR) in neonates is linked to higher urinary Cystatin-C (Cys-C) levels, indicating reduced kidney size. This suggests Cys-C may serve as an early marker for long-term renal disease risk in IUGR infants.

Area of Science:

  • Neonatal nephrology
  • Biochemistry
  • Medical diagnostics

Background:

  • Intrauterine growth retardation (IUGR) impairs fetal kidney development, increasing risk for renal disease.
  • Cystatin-C (Cys-C) is filtered by glomeruli and catabolized by tubules; urinary levels may rise with impaired tubular function or hyperfiltration.
  • Reduced Cys-C degradation in tubular diseases or hyperfiltration could lead to increased urinary excretion.

Purpose of the Study:

  • To assess urinary Cys-C excretion in neonates with IUGR compared to those adequate for gestational age (AGA).
  • To correlate urinary Cys-C levels with renal volumes in IUGR and AGA neonates.
  • To determine the clinical utility of urinary Cys-C as a marker for IUGR.

Main Methods:

  • Urinary Cys-C levels were measured using an enzyme immunoassay (DetectX® Human Cystatin C kit).
  • Renal and renal cortex volumes were assessed using ultrasound (Vocal II; GE Healthcare).
  • Measurements were performed in neonates diagnosed with IUGR and AGA.

Main Results:

  • Urinary Cys-C levels were significantly higher in IUGR neonates compared to AGA neonates.
  • Higher urinary Cys-C levels were negatively correlated with reduced whole renal and renal cortex volumes.
  • These findings suggest a link between elevated urinary Cys-C and diminished kidney size in IUGR.

Conclusions:

  • Elevated urinary Cys-C in IUGR neonates is associated with smaller renal and renal cortex volumes.
  • Urinary Cys-C may serve as a surrogate marker for nephron mass in neonates.
  • Cys-C could be an early biomarker to identify IUGR infants at high risk for future renal disease and guide monitoring.
Abstract

Related Concept Videos

Urinary Tract Calculi I: Introduction01:28

Urinary Tract Calculi I: Introduction

Renal calculi, or kidney stones, are solid deposits of minerals and salts formed inside the kidneys. In medical terminology, "calculus" refers to the stone itself, while "lithiasis" describes the process of stone formation. Depending on their location within the urinary system, these stones may be classified as either urolithiasis, when situated within the urinary tract, or nephrolithiasis, when located within the kidneys. Each term signifies the specific impact of the stone.Predisposition...
857
Factors Affecting Renal Clearance: Renal Impairment01:17

Factors Affecting Renal Clearance: Renal Impairment

Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
549
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
608
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area.
307
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
102
Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance...
340